Aflac Inc. (AFL)
Q4 2009 Earnings Call
February 3, 2010 9:00 am ET
Ken Janke – Senior Vice President, Investor Relations
Dan Amos – Chairman, Chief Executive Officer
Kriss Cloninger – President, Chief Financial Officer
Paul Amos – President of Aflac, Chief Operating Officer of U.S. Business
Jerry Jeffery – Senior Vice President, Chief Investment Officer
Toru Tonoike – President, Chief Operating Officer of Aflac Japan
Jimmy Bhullar - J.P. Morgan
Steven Schwartz - Raymond James
Randy Binner - FBR Capital Markets & Co.
[Sydney Thomas] – Sanford Bernstein
Welcome to the Aflac fourth quarter earnings conference call. (Operator Instructions) I would now like to turn the call over to Mr. Ken Janke, Senior Vice President of Investor Relations.
Thank you, Wendy. Good morning everybody and thanks for taking the time to join us this morning. With me in Columbus is Dan Amos, Chairman and CEO; Kriss Cloninger, President and CFO; Paul Amos, President of Aflac and Chief Operating Officer of our U.S. Business; Jerry Jeffery – Senior Vice President and Chief Investment Officer; and Toru Tonoike, who is President and COO of Aflac Japan, joins us from Tokyo.
Before we begin this morning, let me remind you that some of the statements we’ll make in this teleconference are forward-looking within the meaning of federal securities laws. Although we believe these statements are reasonable, we can give no assurance they’ll prove to be accurate because they’re prospective in nature. The actual results in the future could differ materially from those we discuss today and I’d encourage you to look at our press release from last night for some of the various risk factors that could materially impact future results.
Now I’ll turn it over to Dan who will begin this morning with some comments about the quarter and our operations. I’ll follow up with some financial highlights and then we’ll be pleased to take your questions. Dan?
Thank you, Ken. Good morning and thank you for joining us. Let me begin a review of last year with a discussion of the insurance segment starting with Japan. Aflac Japan posted strong results through 2009. We were happy with the financial performance of our largest earning contributor and we were extremely pleased with Aflac Japan sales results. We had an incredibly strong fourth quarter and sales significantly surpassed our expectations. In fact, the month of December was the largest December in AFLAC’s 35 year history in Japan.
Total annualized premium sales in yen were up 14.9% for the quarter and 6.7% for the year, which surpassed our goal of 0 to 5% increase for the year. Additionally, our large block of in force business was marred by strong persistency as expected and our margins again improved. Our sales growth was mainly propelled by product innovation, effective promotion and channel expansion.
Fourth quarter medical sales were exceptionally strong, rising 57.7% over the fourth quarter of 2008. In August we launched a revision of our popular medical product, EVER. The advertising for this updated EVER product featured the Aflac duck dressed up as the manekineko or beckoning cat that is frequently seen in drawings and figurines throughout Asia. The raised paw of this cat is said to attract good luck and the AFLAC’s duck affiliation with the character links the cat’s good fortune with the positive brand image. For Aflac Japan the manekineko duck campaign created an overnight sensation for consumers of all ages. Most importantly it also helped us sell more than 361,400 EVER policies from the time the new EVER plan was launched through the end of 2009, which exceeded our expectations.
We also continued to experience strong sales in the ordinary life category, which was up 45% and accounted for 30% of the sales in the quarter. The positive reception of a child endowment product we introduced in March was largely responsible for the strong life sales in 2009. During the quarter we sold 27,500 child endowment policies at an average premium of 152,800 yen which is a significantly higher premium than our core medical or cancer products.
In addition to new products, we also achieved greater distribution through the bank channel and our new agency recruitment. Bank channel sales continue to improve and we were a record 2.9 billion yen in the fourth quarter. That represents a 33% increase over the third quarter of 2009 and a 202.7% increase over a year ago. At the end of December, a total of 353 banks represented Aflac Japan. We have a very strong position within the bank channel and have significantly more banks selling for us than any other insurer operating in Japan.
We have also been developing our distribution beyond the bank channel. In that regard traditional agency recruitment remains strong. In the fourth quarter, newly recruited agencies were 22.4% higher than a year ago. For the year we produced a 17.9% increase in recruited agencies. We believe recruiting has not only benefited from the weak economy but also from the strength of the brand and the relevant products, and the improvement in recruiting and training techniques.
As we noted in last night’s press release, Aflac Japan has again targeted flat sales to a 5% increase in 2010. We believe we still have solid momentum in the medical and ordinary product categories to start 2010. Also the first quarter represents a fairly easy comparison to last year. However, the comparisons get tougher as the year progresses, especially in the fourth quarter. In addition, we expect much lower sales contribution from an alternative distribution channel, which are primarily telemarketing based agencies. This type of independent agency has always produced varied sales results. The largest of these agencies has made a large reduction in its number of telemarketers. As a result we expect these sales contributions to be about 50 million lower this year. We also expect to see a decline in the AG Life sales. However, we still believe we’re positioned to have a good year in 2010 and we remain excited about the opportunities we see in the Japan market.
Let me turn to our U.S. operations. As has been the case for the last several quarters, difficult economic environment continues to pose challenges to the U.S. sales growth. As such, we were not surprised that the fourth quarter sales were down 6.3%; for the year sales decline of 6.4%. As you know, our persistency rate has also been impacted by the extended recession which was especially true in the first quarter of 2009. However, the persistency rate of the U.S. business improved steadily as the year progressed. Frankly, it’s disappointing that our sales have declined for two years in a row, but I have to say that in my 36 years with Aflac, I have never seen the economy have such an impact on the U.S. business. I am sure many of you could say the same about your business.
However, we believe that the disruptions in the demand for our product is temporary and reflects the budgetary stress that many U.S. households face. Concerns about job security and the overall consumer confidence levels has impeded our success at the worksite selling. Specifically, the lack of hiring within our existing accounts especially hurt the sales of veteran agents. But as we’ve discussed before, we remain convinced the underlying need for our products is just as strong if not stronger than it’s ever been.
At the same time we’re determined to further strengthen our business model by focusing on the competitive strengths so that we are strongly positioned when economic stability returns. For instance, we continue to enhance our product line with new introductions last year. In particular, we launched what we refer to as essential cancer and accident products. These new products have been streamlined with lower benefit and premium levels. In short, we believe that they’re better suited to the current economy and in the long run they will give consumers more choice.
We also continue to recruit and train new sales associates to expand our reach in the market. Although agent recruitment declined in the fourth quarter, recruitment was up 10.6% for the full year to more than 28,400 new sales associates. Sales growth from associates in their first year was again better than veteran associates, which again proved my point that hiring freezes at existing payroll accounts hurts veteran agents who establish and now manage these accounts.
The number of new, average weekly producers or those who are selling regularly in the first year increased 6.2% for 2009. In addition, new sales associates produced 19.2% increase in new payroll accounts in 2009. This kind of production from new agents indicates that our distribution model is still working and our training is effective.
As you know, we made a strategic acquisition last year that we believe further enhanced our business and position in the marketplace. In October in 2009 we completed the purchase of Continental American Insurance Company, which is now branded as the Aflac Group Insurance. This acquisition equips Aflac with an attractive offering of voluntary group insurance products that should enhance the sales opportunities for our traditional sales force of individual associates. At the same time, group products are well suited for distribution by insurance brokers at the worksite. We believe that broker distribution can enhance and accomplish in our current distribution capabilities. We also believe our broker initiative is taking us in the right direction.
Just last month a survey of 358 brokers conducted by the Business Intelligence Consulting Firm found that Aflac is the number one preferred carrier of voluntary insurance among brokers. We were ranked fourth in 2008. This survey also reveals a 25% increase in familiarity among brokers, which was the largest increase of any insurance carrier.
We have also been active in the area of advertising and branding. We just marked the tenth anniversary of the Aflac duck with a new advertising campaign. Thanks to the Aflac duck, 94% of the consumers know the Aflac brand. But as we’ve discussed over the last several years, advertising and marketing is focused on better explaining the brand, not just promoting it. To that end, we hope that the new animated commercials will help consumers understand more about what Aflac insurance is and exactly how our products can help them. Our current campaign is different. It’s bold and we believe it will further help define our brand.
Last, like last year, our outlook for new sales in the United States remains cautious until we see some stability in the economy. I also want to remind you that we had four extra days production in the first quarter of 2009, which will make this year’s first quarter comparison very difficult. As a result, we expect to see a sizable decline in the first quarter sales of Aflac U.S. For 2010 we have again set our target of 0 to 5% increase in growth. Some of you may feel that the 2010 sales target is too aggressive considering the environment. However, I want to remind you that this target is one of the performance measures for officer bonus compensation. As those of you who know me well should remember that I want to incentivize our officer group for achievement of positive performance. In addition, we still believe strongly in the products we sell.
We are convinced that the potential market for our products in the United States is vast and that consumers will be increasingly receptive to our products once the economy and the employment begins to improve.
From a financial perspective we are very pleased with the fourth quarter 2009 and the full year. Operating earnings were $1.18 per diluted share or up 20.4% for the fourth quarter of 2000. Excluding the impact of the yen, operating earnings per share rose 17.3% for the quarter, a 15% for the full year. Our full year operating earnings growth was in line with our objective of a 13 to 15% increase before the impact of the yen. Throughout the last two decades we have consistently achieved our annual target of operating earnings per share. I believe that accomplishment speaks directly to the strength and resilience of the business models.
As we noted in our press release, net earnings in the fourth quarter were again influenced by larger than normal realized investment losses. In the fourth quarter, we booked $126 million of GAAP only impairments on three perpetual securities using the equity impairment model. You’ll recall that we were required by GAAP accounting to apply an aging schedule of unrealized losses to those perpetual securities that are classified as below investment grade. If there are no additional downgrades to the perpetual securities to below investment grade in the quarter, then we would not expect any equity impairments or perpetual securities holdings in the first quarter of 2010.
You may have noted that we impaired our remaining holdings of Takefuji senior debt in the fourth quarter. As we discussed, we reduced our exposure to Takefuji last year. Our ownership dropped from a par value of $617 million at the end of 2008 to $363 at the end of 2009. Last month we made a determination that the impairment charge was warranted based on the current credit analysis, which suggests that Takefuji may not be able to meet all of its remaining obligations to us. As we noted, net earnings also included the previously announced loss to the exchange of two Lloyd banking groups’ securities.
We generated significant capital through our operations last year which enabled us to absorb investment losses and the impact of the credit rating downgrades. However, we concluded it was prudent to strengthen our capital position even further and did so in December with the issuance of $400 million of 30 year senior notes. With significant capital resources at the parent company level, we decided to make a capital contribution at the end of 2009 from Aflac Incorporated to our principal life insurance subsidiary in the amount of $500 million. We estimate that our year end risk based capital ratio was in excess of 475%, which included a contribution of about 40 points from the capital contribution.
So even excluding the capital contribution, our ratio was significantly higher than the target of 375 we established in early 2009. At year end, our total adjusted capital was approximately $1.3 billion above what was required to support an RBC of 375.
Over the long run, our strong capital generation has allowed us to maintain a policy of steadily increasing the cash dividend even at a time when many companies have either decreased or eliminated the dividend payments. AFLAC’s cash dividend in 2009 was 16.7% higher than they were in 2008. Last year was the 27th consecutive year we’ve increased the dividend. We would certainly like to extend that track record to 28 consecutive years and more. However, I’d like to reiterate that we have previously communicated, before we increase the dividend in 2010 or repurchasing shares, we feel compelled to closely monitor the global financial markets to make sure the worse is behind us. We will also regularly assess our capital levels as measured by the RBC ratio. As much as we would like to see the dividend increase or resume share repurchase, our greatest priority continues to be maintaining a strong capital position.
Yet at the same time, we are still very focused on growing our earnings. In that regard, we have reaffirmed the earnings outlook we previously communicated in 2010. Our goal is to increase operating earnings for diluted share 9 to 12% before the impact of the yen. We believe the achievement of this goal will result from steady, top line growth and continued expansion for Aflac Japan in the margins. Overall, I believe Aflac remains well positioned in the two best insurance markets in the world. The Japanese and U.S. insurance markets share characteristics that make them perfectly suited to the products we offer, and both still have opportunities for growth.
Along with the rest of the world, we will likely face challenges in 2010 and beyond but with the operations that continue to perform well and a balance sheet that remains solidly positioned, I have every confidence in our business model and the fundamental need for our products and most importantly the future success of Aflac. Ken?
Thank you, Dan. Let me briefly take you through some fourth quarter financial highlights starting with Aflac Japan. For the top line in yen terms, revenues rose 3.4% for the quarter while investment income was up 1.2%. Excluding the effect of the stronger yen on Aflac Japan’s dollar denominated investment income, net investment income rose 3.7% in the quarter.
The annualized persistency rate excluding annuities was 94%, which was unchanged from the nine months but down from 94.5% in 2008. The benefit ratio continued to improve over last year and was 59.7% in the fourth quarter compared with 63.6% a year ago. The expense ratio for the quarter was 21.6%, which was up from 20.1% a year ago. The increase in the expense ratio reflected in part increased advertising and promotion as well as higher DAX amortization from the lower persistency rate.
Reflecting the lower benefit ratio, the pretax margin rose from 16.3% to 18.7% in the quarter. Due to the expansion of the margin, pretax earnings [inaudible] 18.5% for the quarter in yen. And again excluding the impact of the stronger yen on a dollar dominated investment income, pretax earnings rose 19.8% in the quarter.
For the quarter we invested our cash flow in yen securities at an average yield of 2.26% and including dollars the blended rate was 2.46%. The lower new money yields in the quarter resulted largely from spread compression and the purchase of higher rated securities. The portfolio yield for Aflac Japan was 3.77% at the end of December, down three basis points from September and 13 basis points lower than a year ago.
For Aflac U.S., total revenues rose 4.3% in the quarter and benefited from the inclusion of the new Aflac Group Insurance segment. The annualized persistency rate for the year was 72.2% compared with 73.2% a year ago. Although it was lower than a year ago, as Dan mentioned, it improved steadily as the year progressed.
The benefit ratio was 53.8% compared with 53.3% in the fourth quarter and the increase in the benefit ratio was due to a year end adjustment of $28 million to IBNR for the accident and cancer product lines. The operating expense ratio was 33.7% compared with 33.5% in the fourth quarter of 2008. And reflecting the higher benefit and expense ratios, the profit margin for the quarter was 12.5% compared with 13.2% a year ago, resulting in a 1.5% decline in pretax operating earnings for the quarter.
In terms of U.S. new money yields, the yield in the fourth quarter of ’09 was 6.25% compared with 9.08% a year ago. The yield on the portfolio at the end of December was 7.17%, down three basis points from September but up seven basis points over a year ago.
Turning to some other items for the quarter, excluding the effect of FAS 115, the ratio of debt to total capital was 22.3% at the end of the year compared with 18% at the end of 2008. Non-insurance interest expense in the fourth quarter was $25 million compared with $7 million a year ago. The higher interest expense reflected the debt issuance earlier in the year and the impact of the stronger yen on yen denominated debt.
Parent company and other expenses were $32 million in the fourth quarter compared with $12 million a year ago. The higher parent company expenses in the quarter primarily resulted from lower investment income at the parent company and even more so realized foreign currency losses on yen assets that are being held at the parent company and had not been designated as a hedge.
The operating margins improved for the quarter on a consolidated basis. The pretax margin rose from 15 to 16.1%. The after tax margin increased from 9.8 to 11%. On an operating basis, the tax rate declined from 34.8 to 31.5%. As we noted in the press release, we recently completed an IRS exam. It was for the tax years 2006 and ‘7. Our provisions for tax payments were higher than we had estimated which resulted in a release of $24 million in the fourth quarter. Since we had accrued those provisions through operating earnings in prior periods, the tax release did flow through operating earnings. For 2010, we would expect the tax rate to return to its prior normal level.
Net earnings per diluted share for the quarter were $0.53, up from $0.42 a year ago. The primary difference between net earnings and operating earnings was again realized investment losses, which were $0.65 per share in the fourth quarter of ’09 compared with $0.56 per share in the fourth quarter of ’08.
I’d like to point out that on January 1 we did adopt SFAS 167, which will require us to consolidate $6 billion of qualified special purpose entities and variable interest entities that we have owned for many, many years. These QSBs and VIEs are trusts that were established for the issuance of reverse dual currency investments or other yen denominated investments. The trusts contain a dollar bond and a swap into yen. Now going forward we will be marking the swaps to market and the gains or losses on those swaps will be reflected in realized investment gains or losses. As such, the impact from FAS 167 will be excluded from operating earnings.
Importantly, the economics of our investments in these securities won’t change, only the accounting for those instruments. And our risk of loss is unchanged and is limited to our original investment. Upon adoption, we have made a one time cumulative adjustment to shareholders equity, which will reduce shareholders equity by approximately $200 million and will be reflected in our March 31, 2010 financials.
As reported, operating earnings per diluted share rose 20.4% to $1.18, which was ahead of our guidance. The stronger yen increased operating earnings by $0.03 per diluted share in the quarter and $0.26 for the year. Excluding the yen’s impact, operating earnings were up 17.3% for the quarter and 15% for the year. If you also exclude the tax benefit of $0.05 per diluted share that flowed through operating earnings, operating earnings per share would have increased 13.8% for the full year, which was consistent with our underlying rate of growth for the first nine months of 2009.
Now lastly let me comment on the outlook for operating earnings per share for 2010. As you heard we have affirmed our objective for this year of a 9 to 12% increase in operating earnings per diluted share before the impact of the yen. That would equate to $5.29 to $5.43 for the full year, assuming no change in the currency rate from last year. This year we estimate that a one yen change on the average exchange rate for the year will equal approximately $0.035 per diluted share. As such, if we achieve our objective of 9 to 12% growth and the yen averages 90 to 95 for the full year, we would expect operating earnings per share to be in the area of $5.24 to $5.52.
We’re now ready to take your questions. We’d like to make sure that everyone has the opportunity to ask a question so please limit your questions to one. And Wendy, now I’ll turn it back over to you for the Q&A.
Thank you. (Operator Instructions) Your first question comes from Jimmy Bhullar - J.P. Morgan.
Jimmy Bhullar - J.P. Morgan
I just had a question on recruiting trends in the U.S. Previously the economy being weak actually had been a blessing. You had been growing recruiting a decent amount. This quarter you saw a downtick, so if you could just address what caused the decline this quarter and then just comments on your outlook for 2010.
Sure. First of all, recruiting for the overall 2010 was extremely strong. Now remember we do have a total training capacity based on our state trainers and their states combined with our district sales coordinators out in the field with a total number of people. We had a extremely strong first three quarters. Those first three quarters really built up to a strong average weekly new producer growth and we felt like the combination of fourth quarter re-enrollments combined with the volume of people that we’d recruited throughout the beginning of the year allowed us to let up a little bit on recruiting. Now obviously comparisons from a 2009 to 2010 standpoint will be a little bit more difficult, but our overall goal is to continue to grow our producers, specifically focusing on our new producers but also re-engaging and re-growing our veteran producers in 2010. So I’m not concerned about the fourth quarter downturn in recruiting. That was planned and projected. But at the same time I think that we will continue to recruit but to do so in a moderate level that allows us to successfully bring on the right number of producers for our business in 2010.
Jimmy Bhullar - J.P. Morgan
And related to that on your U.S. business, besides the comps being easier on sales and also just the incentive comp being linked to positive sales growth, are there other things that you’re doing that give you confidence that you can actually get to positive sales growth this year? If you could just talk about your 0 to 5% guidance.
Sure. Obviously the final number that you all get of 0 to 5% represents a large number of levers that we can be moving in one direction or another. We have a tremendous number of initiatives that we have going on that we believe will strongly influence that. Since my tenure here at worldwide headquarters, we are focused on training. We are going to make sure that we are more effectively training our new agents as well as our veteran agents, bringing out new classes and new things that we think within an economy of this nature will help our agents be more successful with their sales skills as well as with their overall product knowledge and packaging that happens in a time like this or that needs to be sold at a time like this.
We’re also focused on the broker and large account market. Really the final piece necessary for us to be competitive in the accounts over 1,000 was the group platform that we purchased through Continental American, now Aflac Group. So I do believe those right there are large factors. Third would be the marketing campaign. As Dan mentioned the [inaudible] Quack campaign we believe is driving both consumer and business understanding for why the value of our products is necessary either for their business or for them as an individual.
You know the last part is that I really believe or hope that the first half of the year the economy’s going to continue to be difficult but I have hope that the second half of the year the economy will continue to move in the right direction. President Obama stated that small business was a big focus for him on what was going to happen. And we continue to write the vast majority of our accounts in America’s smallest businesses. Those businesses thrive the most during a rising economy and are the ones that are hurt the most during a difficult economy. But overall throughout the history of America, the economy has been very strong and continues to grow. And so we believe that we are hedging our business in the right direction, that we’re in the right market for us and that long term we will continue to get back on the right track.
You know the last comment I’ll make is that you all put me in a position where my focus is to grow the long term sales of this company. It’s not just about [inaudible] something or what first quarter of this year will be but doing what’s right for this business for the long term. And I believe the initiatives we have in place are about making sure that for the long term stability of our growth in sales and not just about trying to produce for first quarter of 2010 but really success for the long term.
Your next question comes from Edward Spehar.
Kriss, I had a question about the capital contributions of the insurance subsidiary. I’m trying to understand why you would put capital down on the sub when the RBC ratio, without the contribution, was 435% or well above what you’ve talked about as a target. I guess the question is you know why not keep it at the holding company and if something bad happens [inaudible] to the sub, why exercise the option instead of holding it?
Okay, Ed, well that’s a legitimate question. You know if we had the benefit of hindsight, we might have done some differently but I’m really not sure we would have. You know we set an objective at the beginning of this year to make sure that we managed risk based capital as the highest priority. And last year we had finished the year at about 475 and we got down to 405 at the end of the third quarter. Many of you expressed concern over the drop between the second and third quarter. I reassured you that we had about $500 million of cash at the holding company I could contribute to the life company to bolster that RBC during the fourth quarter.
You know going into the fourth quarter we were looking at a couple of the rating agencies, talking about changing their methodology for rating perpetual securities. And we didn’t know exactly what that held in store for us, particularly in the latter part of December. You know, we didn’t want to come up to the last two weeks in December and be surprised by significant ratings changes on that category of securities. So really after we released third quarter results and we went through our analyst meetings and our board meetings, and I reflected on what we had to do in 2010, I looked at the strong capital markets in the U.S. and I said well, okay, I’ve got about half of my Samurai note of 40 billion yen that comes due in July, 2010 already refinanced. We had borrowed roughly 15 billion yen earlier in 2009, which covered about half of that.
I still had 25 billion yen to go and I said to myself well, you know with the strong capital markets in the U.S. and I was told that we ought to explore the capital markets in Japan, you know that those might open up. So we actually did some inquiries as to whether we could do another Samurai transaction in late November or early December in Japan. And we concluded at that time that our usual sources of Samurai funds still weren’t receptive to foreign financials. So we decided to pull back from the Samurai market and we decided okay, in the strong capital market in the U.S. we were going to go ahead and borrow the extra $400 million in December in the U.S., which we did.
And at the same time we had scheduled repatriation from Japan for about 20 billion yen. So we went ahead and took that into the parent company, so that gave us 35, 36 billion yen of funds at the parent company. And then we were looking at having about $600 million of cash at the holding company and we thought well, what’s the best utilization of that? Well, we don’t get any credit for anything if the funds are at the holding company. We don’t really have any long term concern about being able to get capital out of the life company, Ed. So we decided we would rather have the insurance against rating agency actions on the perpetuals adversely affecting our risk based capital position, so we decided to contribute $500 million to the life company as the most efficient use of funds.
So we did it primarily to bolster our RBC position. At the same time we assured that we’ve got adequate funds at the holding company to pay off the next maturing Samurai note. So that’s a long answer to a short question. I apologize, but I thought I needed to walk you through the thought process.
Your next question comes from Steven Schwartz - Raymond James.
Steven Schwartz - Raymond James
I wanted to talk about CAIC a little bit. First, any metrics maybe you can offer about the progress there. I know you stated that a poll suggested you were the number one favorite for brokers but I’m just wondering if there are any metrics you could talk about and how that’s progressing in the integration of that, particularly with your agents. And as well I’m looking at the sales breakdown for the U.S. There is one area that did increase. That was hospital indemnity plans. I think CAIC does Mini Med. I was wondering if you could touch on that product, what exactly that is. And I’ll just leave it at that.
Sure. First of all, CAIC now Aflac Group had a tremendous number of enrollments set up for the fourth quarter prior to our purchase and our top two goals obviously were integration from a technology and platform standpoint as well as making sure that they were effective in the enrollments they already had set. We were less concerned about attempting to write business from an Aflac perspective with 2010 really being our launch for an integrated marketing and sales effort.
In terms of the metrics that we’re taking a look at, obviously we’re less concerned about what business is written in an individual versus a group platform. We’re more concerned about the totality of the business that’s grown. That said, we understand that you’re going to want to look at things both by channel as well as by product type. You know we do not believe that broker and individual are synonymous with group and individual. Those are four different groupings that can be done in either direction and we need to make sure we differentiate on how those are looked at because both individual agents can offer both types of products, as well as brokers can offer both types of products. And we feel like offering both will be essential for our long term growth.
In terms of the sales of the [Mid] Med product specifically, that product is a different product than is traditionally sold at Aflac. We have made the decision that we will be shutting down the sale of that product for all future policies at CAIC based on the date of the last business proposals that we had out with brokers. We’re going to continue to follow through with the commitments that we had made, but effectively we are shutting down the sales of that product. Of the sales in the fourth quarter of $26.8 million at CAIC, $6.4 million of those were the Mid Med. We did not believe that was a product core to what we wanted. Again this was a technology purchase for us. The capability to use the group platform and to use the intelligent people they have to help us do group platform benefits with flexibility, to meet the needs of large accounts and brokers and otherwise. It was not about trying to get into a major medical or comprehensive medical program.
As such we’ve made that decision and are moving forward with it. I hope that answers your question. In terms of the [HIP] business that you talked about, that is just AFLAC’s HIP. HIP continues to be a driving force based on American consumers seeing benefits and their major medical plans continue to erode. And so our HIP business does continue to be a strong reason for sales in the U.S.
Steven Schwartz - Raymond James
On that page, where’s the Mid Med located?
He’s saying it’s in the HIP. I’m sorry, I get a more broken down report than what you guys have put out here. He’s showing it to me right now. Mine is much more detailed and I take it out of the HIP plan. That small amount is in, but it was only represented $6.4 million for the entire year in terms of sales on HIP because we only took the CAIC numbers for the fourth quarter.
Your next question comes from Randy Binner - FBR Capital Markets & Co.
Randy Binner - FBR Capital Markets & Co.
Just a question on the standalone medical products in Japan, obviously it was very successful, 43% of all new sales. Just trying to get some color on if there was seasonality there or if there was a year end push? You know, trying to get to how sustainable that level of sales contribution on that product might be.
Okay. I think it’s a chance to let Toru talk and brag a little bit about what all’s going on, because there’s a phenomenon going on in Japan in terms of what has happened from a marketing campaign. And also the results of what’s happened with new sales, specifically of the new EVER product. So Toru, go ahead.
Yes. When we started to form the introduction of the new EVER which was introduced in late August last year, it took us maybe two to three months to make all the preparations. And we planned it as a sort of multi-faceted plan in which we tried many things. We planned that what our branches and the Asians should do in preparation for the introduction of the new product, which customers are they expected to sell and how they plan to do it. And we do it individual agents or small independent agents and the big affiliated agents separately. So we spent some time on it.
Also we planned the new TV commercials featuring new character called Mane Kineko Cat, which Dan explained a few minutes ago. And those we planned to time airing the commercials at the right timing. Right around the time of the introduction we ran the commercials very heavily so that image of the new character, Mane Kineko Cat, and our new product is very well received by the general public.
And right before the introduction we planned a big press conference pre-release of the new product, hosted by a very famous and popular actress, Aoi Miyazaki. She shows up in the commercial and she is extremely popular in Japan. So thanks to the participation of Aoi it attracted a large number of the media people, over 200. And it was well covered by various media, TV, [managings] and the newspapers.
Also we created the big character, Mane Kineko, in the size of six feet tall. And we made three of them, put them in a large bus and the bus caravanned all over Japan for about three or four months. And using that bus we hosted a town festival type of event in about a dozen places in the big cities. And those events attracted large number of people. So for example the first one was held at [inaudible] in Tokyo and that event attracted about 20,000 people in two days. So you can imagine how big the participants was.
So over time we were able to build up the popularity of the new product. So the sales were very good from the very beginning and consistently kept growing. So that’s why our year end number was larger than the home quarters. So the momentum continues. I don’t think that will grow forever but the momentum still continues and we expect it last fairly long. I don’t know exactly when it slows down.
Let me say one other thing, Toru. Just to give the analysts some idea of how big this thing is, 20,000 people showing up at a location tells you something, but our commercials have been number one in financial services before, but the actual new commercial with the Mane Kineko Duck is the number one commercial in all of Japan in any category whatsoever, beating soft drinks, beating computers, beating anything. And so it has created such a buzz that that on top of having a superior product is what’s driving this.
Randy Binner - FBR Capital Markets & Co.
It seems like Japan Post is not coming up as much in the conversation. Is there any update on the impact of the new government there on the privatization effort at the Post?
No. I’ll answer that. You know I have said all along, if you’ll remember back when we got the banking channel and we got the Post I always said that I expected the real winner to be the banking channel, because we had worked in this environment, it had been great for us and it has really taken off. And I give again Shengkai again a large credit for what’s taken place there.
In regard to the Post, we are still working with them. The sales are up over last year but they are insignificant in relationship to say what the banking channel is doing. But we continue to work with them, we’re encouraged that they will continue to grow that market for us, but they are very bureaucratic and they go at their own pace and we have very little control in pushing them. So we just have to kind of fall in line of what they consider acceptable. But I do feel like that we’ve got a great marketing team working on it and the potential’s there. But I don’t see any major change in 2010 except for a continued increase.
Let me add just one thing. As Dan mentioned it’s still a small contributor and was less than 1% of sales for ’09 which is why we didn’t break it out. In terms of what’s going on with the current government in Japan, you may have seen that last year there was legislation put forth to freeze the pending IPOs of the various postal entities. And now the government is basically regrouping to see what the best organization might be. For instance, one of the proposals is to have the postal operations be folded in to a holding company and then leave the insurance and the banks as separate subsidiaries to that. This is all pretty much in a state of flux and for those of you that consume the English versions of the Japanese press I think you’ll be getting more articles out of it in the coming months as the government starts floating what may be no more than trial balloons or may be appear in the press about what the future might look like for the Post.
Your next question comes from Andrew Kligerman.
In trying to frame the Continental American position, just a few data points, what would be a typical premium for an account with more than 1,000 employees? That’s Part A. Part B is is there any type of conflicts given that Continental American is more of a broker market. Would there be a conflict between your agents and those producers going forward?
Andrew, of course channel conflict is one of the things that we would immediately want to mitigate, as you can imagine. There are circumstances in the past where other companies have brought together a broker and a field force channel where that has not worked well. And I think we have taken and learned from their experience. As you can imagine, there are different products with different commission structures and by giving access to both channels, the field force as well as the broker channel, to all of those products we believe that’s the first step in mitigating some of that channel conflict.
Additionally, we have found a way to de-leverage our current commission structure so that we can pay brokers more than they would be receiving if they were to use an enrollment company and by using our Aflac field force as their enrollment company. So if we can ultimately pay our new brokers a higher level of commissions and at the same time pay our field force, there should not only be no channel conflict. It should be a win, win situation in terms of what we were able to bring together by having the world’s best distribution force now with a budding broker market.
In terms of the account side as in the average premium per account size, we’re just not getting into that at this time. You know first of all that is based on the previous success of what Continental American did in their previous accounts, based on the varying sizes of those accounts and the number of them, I just think it would be statistically invalid for a company of our size to comment at this time. By [fab] I may be able to give you a deeper set of data on how that works, but what I can tell you is that the average premium sizes are within the same range in terms of a per certificate or per policy basis between Aflac U.S. and Aflac Group.
Randy Binner - FBR Capital Markets & Co.
One last part to it then, Paul, maybe minus that Mid Med product you don’t want to continue, so they did about $20 million in the fourth quarter. Just in terms of your excitement, I mean do you think you could do dramatically better than that? Do you get real excited net net with this new platform for Group?
In the long term I do believe the platform for group will add considerable business but 2010 is yet to be determined. You know in terms of the broker market itself Aflac has a long history of going head to head with the brokers, and as a result I think it’s essential for us to continue to build relationships within that broker market. Ron Agypt and our entire broker team are out working with our Aflac Group team to continue to build recognition within that market, but the majority of the business in any broker market is always going to be written in the fourth quarter. As a result, really and truly we won’t know a lot about how tempered and big that excitement will be until we get to the latter half of the year. So we continue to push it, I continue to have high hopes for it, but again when you base it on the size of sales that we did in 2010 in our individual or field force channel, it’s just so large in proportion to what the broker business is today, that I don’t believe even a large increase is going to have a considerable effect on the overall. But for the long term viability of the business I do believe that both channels, our continued core channel, 500 and under, field force focusing on the sales, continues to be the core of what will be but the enhancement of the broker market and large accounts will continue to be something that will help grow the business also.
And Andrew, let me comment on national health care because this all kind of ties together. Of course because of what took place in Massachusetts, there’s a big change taking place. But I think it’s important to note that we are well positioned under any particular program that was brought on by either the House or the Senate side. We’ve still positioned ourself in a way that whether it’s major medical insurance at the worksite or it’s national healthcare at the worksite, that ours will help supplement those particular programs. Or whether it’s national healthcare in Japan or these programs here in the U.S. So I think it’s worthy to note as we’ve moved through this year or moved through 2009, where there was such discussion about healthcare, that we’re still positioned in a way that we should do very well in whatever environment should take place from that standpoint.
Your next question comes from [Sydney Thomas] – Sanford Bernstein.
[Sydney Thomas] – Sanford Bernstein
First just a quick follow up to Andrew’s question about the group business, maybe for Kriss. Is the pricing and the underwriting discipline I guess ultimately the margin on the group product similar to what you’re seeing in terms of the products sold by the individual agents in the U.S.?
Yes. Overall net margin is pretty similar to the Aflac traditional margin on health products. The expense ratio is slightly higher. The benefit ratio’s slightly lower but net, net it’s a similar margin.
[Sydney Thomas] – Sanford Bernstein
Second question on capital, you talked about maybe not doing anything just yet in terms of buybacks and dividends. You talked about $1.3 billion of stat capital cushion if you will relative to 375 RBC and maybe $2 billion of stat earnings for 2010, maybe a little bit higher than that. So as you think about capital cushion of maybe $3 billion sort of changing over time, how would you think about redeploying capital buybacks versus dividends? And Dan you had mentioned the track record in terms of dividend increases. Is it fair to assume then that if you’re going to do anything in terms of capital redeployment it would likely start with a dividend increase and then buyback? Or how do you think about that?
Well, my first comment is what a difference a year makes. But I’ll let Kriss answer.
Well, we have a long history, I forget how many years it is, 27, 28 years of increasing the dividend every calendar year. And you know we’d hate for that record to go by the wayside. We believe that we had a strong year in 2009, given the environment. We finished the year at about the same RBC that we entered the year and we went through a lot of trauma in between January 1 and December 31. But we finished the year strong and we were not expecting 2010 to be as challenging as 2009. You know last year we told the analyst community and the rating agencies we expected that we could earn our way through any difficulties and we still believe that to be the case.
Given that, and given the references to our capital position and the like, you know we think we’ll be in a position to consider a dividend increase later in 2010. Relative to share repurchase, we had a consistent share repurchase program in place from 1994 through 2008. We purchased shares every year and virtually every quarter during that period of time. And we still believe that share repurchase is an effective way for us to use capital we don’t otherwise need in the operation. We aren’t in a position yet to say we don’t want to retain the capital we’ll internally generate. We’re not yet in a position to say that, but I think it’s fair to say that we don’t anticipate we’ll be raising any external capital. That being said, you know, if the conditions continue to stabilize and improve then I think our outlook for deploying excess capital we’re generating will probably be deployed in share repurchase at some point in the future when we’re comfortable that we’ve reached just a comfortable level, with a reasonably good outlook for the future. So that’s our internal view on the thing.
Wendy, my clock is showing that we’re very close to the top of the hour and out of respect to another company in our industry I know there is a 10:00 call that’s going to pull a lot of these participants away to that call. So we’re going to conclude our call at this time. I apologize if we didn’t get to everybody who had a question. If you still have a question, feel free to either email Robin [Wilke] or myself or call our 800 number and we’d be happy to talk with you and we’ll get back with you just as soon as we can. And thanks again for joining us this morning.
Thank you. This does conclude today’s conference. Thank you for participating. You may disconnect at this time.
Copyright policy: All transcripts on this site are the copyright of Seeking Alpha. However, we view them as an important resource for bloggers and journalists, and are excited to contribute to the democratization of financial information on the Internet. (Until now investors have had to pay thousands of dollars in subscription fees for transcripts.) So our reproduction policy is as follows: You may quote up to 400 words of any transcript on the condition that you attribute the transcript to Seeking Alpha and either link to the original transcript or to www.SeekingAlpha.com. All other use is prohibited.
THE INFORMATION CONTAINED HERE IS A TEXTUAL REPRESENTATION OF THE APPLICABLE COMPANY'S CONFERENCE CALL, CONFERENCE PRESENTATION OR OTHER AUDIO PRESENTATION, AND WHILE EFFORTS ARE MADE TO PROVIDE AN ACCURATE TRANSCRIPTION, THERE MAY BE MATERIAL ERRORS, OMISSIONS, OR INACCURACIES IN THE REPORTING OF THE SUBSTANCE OF THE AUDIO PRESENTATIONS. IN NO WAY DOES SEEKING ALPHA ASSUME ANY RESPONSIBILITY FOR ANY INVESTMENT OR OTHER DECISIONS MADE BASED UPON THE INFORMATION PROVIDED ON THIS WEB SITE OR IN ANY TRANSCRIPT. USERS ARE ADVISED TO REVIEW THE APPLICABLE COMPANY'S AUDIO PRESENTATION ITSELF AND THE APPLICABLE COMPANY'S SEC FILINGS BEFORE MAKING ANY INVESTMENT OR OTHER DECISIONS.
If you have any additional questions about our online transcripts, please contact us at: email@example.com. Thank you!